Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 38, Issue 5, Pages 489-498Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2017.02.005
Keywords
-
Categories
Funding
- Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3, CO 291/5-1]
- Human Frontier Science Program (HFSP) [RGP0013]
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Canada Foundation for Innovation
- Canada Research Chairs program
- NSERC
Ask authors/readers for more resources
The past decade has yielded tremendous insights into how cells die. This has come with our understanding that several distinct forms of cell death are encompassed under the umbrella term necrosis. Among these distinct forms of regulated necrotic cell death, ferroptosis has attracted considerable attention owing to its putative involvement in diverse pathophysiological processes. A key feature of the ferroptosis process is the requirement of phospholipid peroxidation, a process that has been linked with several human pathologies. Now with the establishment of a connection between lipid peroxidation and a distinctive cell death pathway, the search for new small molecules able to suppress lipid peroxidation has gained momentum and may yield novel cytoprotective strategies. We review here advances in our understanding of the ferroptotic process and summarize the development of lipid peroxidation inhibitors with the ultimate goal of suppressing ferroptosis-relevant cell death and related pathologies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available